Search research articles
Contact Us
Filters
Showing results (161-170 of 196) with videos related to
Page
of 20
Sort By:
Journal of the American Geriatrics Society
|
May 16, 2000
Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study
S S Yeh, S Y Wu, T P Lee, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin
J H Marsh, W Kreis, B Barile, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 22, 2007
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
Michael W Schuster, Tsiporah B Shore, John G Harpel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1985
Interleukin 2-dependent release of interleukin 3 activity by T4+ human T-cell clones
A A Ythier, M Abbud-Filho, J M Williams, et al.
Annals of Hematology
|
February 4, 2026
Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant
Devki D Sukhtankar, Pina M Cardarelli, Bita Jalilizeinali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma
J F DiPersio, M W Schuster, C N Abboud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin
C Isaacs, N J Robert, F A Bailey, et al.
Leukemia
|
November 11, 2006
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
S Jagannath, P G Richardson, P Sonneveld, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2001
Plant growth in elevated CO2 alters mitochondrial number and chloroplast fine structure
K L Griffin, O R Anderson, M D Gastrich, et al.
Bone Marrow Transplantation
|
February 1, 1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF
C S Rosenfeld, B Bolwell, A LeFever, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 196) with videos related to
Sort By:
Page
of 20
Journal of the American Geriatrics Society
|
May 16, 2000
Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study
S S Yeh, S Y Wu, T P Lee, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin
J H Marsh, W Kreis, B Barile, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 22, 2007
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
Michael W Schuster, Tsiporah B Shore, John G Harpel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1985
Interleukin 2-dependent release of interleukin 3 activity by T4+ human T-cell clones
A A Ythier, M Abbud-Filho, J M Williams, et al.
Annals of Hematology
|
February 4, 2026
Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant
Devki D Sukhtankar, Pina M Cardarelli, Bita Jalilizeinali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma
J F DiPersio, M W Schuster, C N Abboud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin
C Isaacs, N J Robert, F A Bailey, et al.
Leukemia
|
November 11, 2006
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
S Jagannath, P G Richardson, P Sonneveld, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2001
Plant growth in elevated CO2 alters mitochondrial number and chloroplast fine structure
K L Griffin, O R Anderson, M D Gastrich, et al.
Bone Marrow Transplantation
|
February 1, 1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF
C S Rosenfeld, B Bolwell, A LeFever, et al.
Page
of 20